Onconetix, Inc. Common Stock

ONCONASDAQUSD
1.02 USD
0.28 (38.02%)AT CLOSE (11:59 AM EDT)
0.81
0.21 (20.40%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
0.81
0.21 (20.40%)
🔴Market: CLOSED

ONCO is currently priced at $1.02. ONCO shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, ONCO appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Sep 4, 2026.

Open?$0.74
High?$1.05
Low?$0.71
Prev. Close?$0.74
Volume?6.7M
Avg. Volume?458.5K
VWAP?$0.94
Rel. Volume?14.53x
Bid / Ask
Bid?$0.81 × 1.3K
Ask?$0.83 × 400
Spread?$0.03
Midpoint?$0.82
Valuation & Ratios
Market Cap?4.5M
Shares Out?3.9M
Float?3.3M
Float %?83.9%
P/E Ratio?N/A
P/B Ratio?0.33
EPS?-$2.33
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Employees
2
Market Cap
4.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-02-18
Address
201 E. FIFTH STREET
CINCINNATI, OH 45202
Phone: 513-620-4101
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
33
Short Sent.?
71
Piotroski F-Score?1/9Weak
Altman Z-Score?-13.86Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.59%Low
Short Interest?152.1K
Days to Cover?1.0
Free Float3.3M
Avg Daily Volume182.2K
Settlement Date2026-08-14
Financial Health
Current Ratio?2.21Strong
Quick Ratio?2.14Strong
Cash Ratio?2.02Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.33CHEAP
P/S?
Peers
100
S&P
17
6.92FAIR
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
0.2CHEAP
EV/Sales?
S&P
97
-2.05CHEAP
Returns & Efficiency
ROE?
S&P
3
-75.7%WEAK
ROA?
S&P
3
-62.1%WEAK
Cash Flow & Enterprise
FCF?$-10307962
Enterprise Value?$-1323723
Fundamentals ratios updated end of day